Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
June 06, 2024 09:00 ET
|
Sermonix Pharmaceuticals Inc.
IND approval in China allows Shanghai Henlius Biotech, Sermonix’s Chinese development partner for oral lasofoxifene, to enroll ELAINE-3 trial patients in ChinaUnder strategic collaboration agreement...
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
June 03, 2024 08:00 ET
|
23andMe, Inc.
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
May 22, 2024 15:35 ET
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
نظير مبادرته الرائدة في مجال غسيل الكلى المنزلي "التخصصي" يفوز بجائزة التأثير التقني من VBHC للعام 2024
May 16, 2024 11:23 ET
|
King Faisal Specialist Hospital & Research Centre
الرياض, May 16, 2024 (GLOBE NEWSWIRE) -- فاز مستشفى الملك فيصل التخصصي ومركز الأبحاث بجائزة التأثير التقني للعام 2024، المقدمة من مركز الرعاية الصحية القائمة على القيمة الأوربي (Value-Based Health...
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC
May 16, 2024 11:23 ET
|
King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
May 13, 2024 09:41 ET
|
King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value
May 11, 2024 06:01 ET
|
King Faisal Specialist Hospital & Research Centre
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending ValueDr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
May 09, 2024 09:00 ET
|
Curia Global, Inc.
The symposium, Unlocking High-Throughput Biology in Drug Discovery, will take place on May 31 in Seattle and feature industry-leading scientists.
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
May 09, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024...